With the passing of the Medication Access and Training Expansion (MATE) Act in December 2022, a new one-time training requirement went into effect for DEA registrants.
- This one-time requirement is for eight hours of accredited training related to the treatment and management of patients with opioid or other substance use disorders.
- You must attest to having fulfilled the requirement the first time that you renew your DEA registration on or after June 27, 2023.
How can you fulfill the requirement?
Addiction Medicine or Addiction Psychiatry Certification
If you are board certified in addiction medicine or addiction psychiatry, you are deemed to have fulfilled the requirement.
Qualifying Recent Graduates
If you graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training on the following criteria, you are deemed to have fulfilled the requirement:
- Treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or
- Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.
Eight Hours of Accredited Training
Complete a total of eight hours of accredited training on treatment and management of patients with opioid or other substance use disorders.
- The training does not have to occur in one session. It can be cumulative across multiple sessions that equal eight hours of training.
- Past trainings provided by one of the Approved Accredited Groups* on the treatment and management of patients with opioid or other substance use disorders can count towards the requirement, even if you completed the training prior to the enactment of this new training obligation on December 29, 2022.
- Past DATA waiver trainings (prescriber training for the use of buprenorphine for opioid use disorder) count towards a DEA registrant’s 8-hour training requirement.
- Trainings can occur in a variety of formats, including classroom settings, seminars at professional society meetings, or virtual offerings.
*Approved Accredited Groups
- The American Society of Addiction Medicine (ASAM)
- The American Academy of Addiction Psychiatry (AAAP)
- American Medical Association (AMA)
- The American Osteopathic Association (AOA), or any organizations accredited by the AOA to provide continuing medical education
- The American Dental Association (ADA)
- The American Association of Oral and Maxillofacial Surgeons (AAOMS)
- The American Psychiatric Association (APA)
- The American Association of Nurse Practitioners (AANP)
- The American Academy of Physician Associates (AAPA)
- The American Nurses Credentialing Center (ANCC)
- Any other organization accredited by the Accreditation Council for Continuing Medical Education (ACCME) or the Commission for Continuing Education Provider Recognition (CCEPR), whether directly or through an organization accredited by a State medical society that is recognized by the ACCME or CCEPR
- Any other organization approved or accredited by the Assistant Secretary for Mental Health and Substance Use, the ACCME, or the CCEPR
Training Opportunities Sponsored by the University of Iowa Carver College of Medicine
Courses will be added as they are identified.
Training Opportunities Sponsored by Other Organizations
Courses listed here are not sponsored by the University of Iowa Carver College of Medicine. It is the responsibility of individual learners to determine what training meets their needs.